These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effects of osmotic-release methylphenidate in attention-deficit/hyperactivity disorder as measured by event-related potentials. Sawada M; Iida J; Ota T; Negoro H; Tanaka S; Sadamatsu M; Kishimoto T Psychiatry Clin Neurosci; 2010 Oct; 64(5):491-8. PubMed ID: 20923428 [TBL] [Abstract][Full Text] [Related]
24. Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate. Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Camfferman G; Buitelaar JK; Koelega HS Psychophysiology; 2000 May; 37(3):334-46. PubMed ID: 10860411 [TBL] [Abstract][Full Text] [Related]
25. Spatial orienting and focused attention in attention deficit hyperactivity disorder. Novak GP; Solanto M; Abikoff H Psychophysiology; 1995 Nov; 32(6):546-59. PubMed ID: 8524989 [TBL] [Abstract][Full Text] [Related]
26. Electrophysiological indices of information processing in methylphenidate responders. Winsberg BG; Javitt DC; Silipo GS Biol Psychiatry; 1997 Sep; 42(6):434-45. PubMed ID: 9285079 [TBL] [Abstract][Full Text] [Related]
27. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity]. Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F Encephale; 1997; 23(4):251-6. PubMed ID: 9417389 [TBL] [Abstract][Full Text] [Related]